MECHANISMS OF CARDIOVASCULAR DISEASES DEVELOPMENT IN OBESITY AND INSULIN RESISTANCE: FOCUS ON ATHEROTHROMBOSIS

QR Code

MECHANISMS OF CARDIOVASCULAR DISEASES DEVELOPMENT IN OBESITY AND INSULIN RESISTANCE: FOCUS ON ATHEROTHROMBOSIS

Article takes into consideration pathogenetic mechanisms of cardiovascular diseases development in obesity and insulin resistance, approaches to atherothrombotic complications prevention. The issues of resistance to antiplatelet drugs are condsidered and possible ways for its overcome. The data ...

Full description

Saved in:

Bibliographic Details
Main Author:	V. N. Shishkova
Format:	Article
Language:	Russian
Published:	«FIRMA «SILICEA» LLC 2016-09-01
Series:	Российский кардиологический журнал
Subjects:	obesity diabetes atherothrombosis insulin resistance hyperglycemia clopidogrel aspirin clapitax
Online Access:	https://russjcardiol.elpub.ru/jour/article/view/921
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ASPIRIN IN THE PREVENTION OF ATHEROTHROMBOSIS AND CORONARY HEART DISEASE
by: M. G. Bubnova
Published: (2010-08-01)

THE ROLE OF MODERN ANTIPLATELET THERAPY IN PREVENTION OF ATHEROTHROMBOSIS: THE IMPORTANCE OF CLOPIDOGREL AND ITS GENERIC DRUGS
by: O. V. Gaisenok
Published: (2016-01-01)

CLOPIDOGREL FOR SELECTIVE MYOCARDIAL REVASCULARIZATION
by: N. V. Teplova
Published: (2016-03-01)

COMPARISON OF THE ORIGINAL (PLAVIx) AND GENERIC (CLAPITAx) CLOPIDOGREL ON PLATELET AGGREGATION: ObSERVATIONAL STUDY
by: A. S. Skotnikov, et al.
Published: (2018-05-01)

The role of modern antithrombotic agents in cardiovascular disease prevention
by: O. M. Drapkina, et al.
Published: (1970-01-01)

RESISTANCE TO ANTIPLATELET DRUGS (ASPIRIN, CLOPIDOGREL) IN PATIENTS UNDERGOING ELECTIVE PERCUTANEOUS CORONARY INTERVENTION
by: V. A. Sulimov, et al.
Published: (2015-12-01)

CLINICAL SIGNIFICANCE OF ASPIRIN RESISTANCE IN PATIENTS WITH CARDIO-VASCULAR DISEASES
by: P. J. Dovgalevsky, et al.
Published: (2016-01-01)

Insulin resistance contribution to pathogenesis of cardiac remodeling in patients with hypertension in combination with obesity and type 2 diabetes
by: M. E. Statsenko, et al.
Published: (2020-05-01)

Research hotspots and trends in obesity and insulin resistance: A bibliometric analysis
by: Hui-xin Yan, et al.
Published: (2025-07-01)

Comparative study of specific activity of rectal suppositories with clopidogrel
by: I. L. Kechyn, et al.
Published: (2021-12-01)

Hemostasis protein-coding genes, peripheral hemostasis parameters, and atherothrombosis predisposition in patients with cardiovascular disease
by: G. I. Lifshits, et al.
Published: (2011-08-01)

Clinical Features and Insulin Resistance in Men with a Metabolically Unhealthy Obesity Phenotype
by: E. I. Panova, et al.
Published: (2020-07-01)

ROLE OF THE ANTIPLATELET DRUGS IN TREATMENT OF STABLE ANGINA: COMMON SENSE AND NON-RESOLVED ISSUES
by: V. V. Yakusevich, et al.
Published: (2015-07-01)

ANTIAGGREGANT THERAPY AND REDUCTION OF HIGH RESIDUAL PLATELET REACTIVITY
by: N. A. Mazur, et al.
Published: (2012-08-01)

Sympathetic nerve activity in obesity-associated insulin resistance
by: Shuchou Xia, et al.
Published: (2025-07-01)

The role of hyperinsulinemia and insulin resistance in the pathogenesis of nephropathies in obesity (literature review)
by: L. V. Kutsenko, et al.
Published: (2021-06-01)

Data-driven cluster analysis on the association of aging, obesity and insulin resistance with new-onset diabetes in Chinese adults: a multicenter retrospective cohort study
by: Yazhi Wang, et al.
Published: (2025-07-01)

MONITORING OF THE EFFECTIVENESS OF ANTIPLATELET THERAPY IN CARDIOLOGY PRACTICE
by: N. F. Puchinian, et al.
Published: (2017-03-01)

Relationship of plasma aldosterone levels and carbohydrate metabolism in heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2021-02-01)

Hyperlipoproteinemia(a) as a dangerous genetically determined violation of lipid metabolism and a risk factor for atherothrombosis and cardiovascular diseases
by: O. I. Afanasieva, et al.
Published: (2019-06-01)

Prognostic value of the Metabolic Score for Insulin Resistance in the development of myocardial infarction in patients with coronary artery disease and obesity after coronary stenting
by: A. V. Svarovskaya, et al.
Published: (2022-11-01)

ASPIRIN RESISTANCE CANDIDATE GENES AND THEIR ASSOCIATION WITH THE RISK OF CARDIOVASCULAR EVENTS
by: Yu. I. Grinshtein, et al.
Published: (2013-02-01)

PREVENTIVE ACTION OF ORLISTAT ON CARDIOVASCULAR RISKS IN YOUNG OBESITY PATIENTS
by: E. V. Korneeva
Published: (2015-08-01)

A RESISTANCE TO LEPTIN IN DEVELOPMENT OF DIFFERENT OBESITY PHENOTYPES
by: A. V. Ott, et al.
Published: (2016-04-01)

Antiplatelet treatment and gastro-intestinal hemorrhage risk
by: D. V. Duplyakov
Published: (2005-08-01)

Aspirin vs. P2Y12 Inhibitor Rivalry: Which One Can be Continued During Gastrointestinal Bleeding
by: Muhammad Begawan Bestari, et al.
Published: (2019-11-01)

Aspirin vs. P2Y12 Inhibitor Rivalry: Which One Can be Continued During Gastrointestinal Bleeding
by: Muhammad Begawan Bestari, et al.
Published: (2019-11-01)

Efficacy and Safety of Dual Antiplatelet Therapy Using Cilostazol with Aspirin or Clopidogrel to Reduce the Rate of Recurrent Ischemic Stroke in Asia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Hendrawan Chandra Kusuma, et al.
Published: (2025-05-01)

Efficacy and Safety of Dual Antiplatelet Therapy Using Cilostazol with Aspirin or Clopidogrel to Reduce the Rate of Recurrent Ischemic Stroke in Asia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
by: Hendrawan Chandra Kusuma, et al.
Published: (2025-05-01)

Correction of carbohydrate metabolism in the use of a cybernetic complex of insulin therapy after transplantation
by: O. N. Rzhevskaya, et al.
Published: (2018-08-01)

IRISIN, OBESITY AND TYPE II DIABETES MELLITUS
by: Zainab Fathi, et al.
Published: (2025-03-01)

Investigating the Role of GDF-15 in Diabetes and Obesity: A Comprehensive Analysis of a Cohort from the KDEP Study
by: Jehad Abubaker, et al.
Published: (2025-06-01)

Methods for assessing insulin resistance in gestational diabetes mellitus
by: N. I. Volkova, et al.
Published: (2022-03-01)

Association between Sympathetic Nervous System Activation, Obesity and Insulin Resistance
by: A. I. Kochetkov, et al.
Published: (2019-05-01)

ANTI-INFLAMMATORY EFFECT OF CLOPIDOGREL IN ATHEROSCLEROSIS
by: L. I. Buriachkovskaia, et al.
Published: (2016-01-01)

THE IMPACT OF RISK FACTORS AND INSULIN ADMININSTRATION METHOD ON THE CONDITION OF THE RETINA IN CHILDREN WITH TYPE I DIABETES MELLITUS
by: A. N. Samoylov, et al.
Published: (2018-10-01)

Loss of IQGAP1 Lends Advantage to Female Mice Against Predisposition to Type 2 Diabetes
by: ashaq hussain, et al.
Published: (2025-06-01)

THROMBOPHILIA AND INTENSITY OF THE INTRAVASCULAR MICROCOAGULATION IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE, ATHEROTHROMBOSIS
by: E. A. Shelest, et al.
Published: (2015-09-01)

RELATIONSHIP OF OBESITY PARAMETERS AND ADIPOKINES WITH THE RISK OF 2ND TYPE DIABETES DEVELOPMENT IN A YEAR AFTER MYOCARDIAL INFARCTION
by: O. V. Gruzdeva, et al.
Published: (2015-04-01)

Adiponectin and insulin: molecular mechanisms of metabolic disorders
by: E. G. Uchasova, et al.
Published: (2020-10-01)